Institutional Ownership Aurinia Pharmaceuticals Inc. (AUPH)
This table provides information about the institutional ownership of Aurinia Pharmaceuticals Inc. (AUPH). We have compiled data on the 240 institutions that hold shares in the stock, with a total of 65.2 Million shares, which have been reported (via 13F filing form) to have a value of $562 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Tang Capital Management LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
10,029,500
shares
|
$89.1 Million
5.24% of portfolio
|
Q1 2025
Added 18.98%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
9,272,162
shares
|
$82.3 Million
0.0% of portfolio
|
Q2 2024
Added 7.03%
|
|
Armistice Capital, LLC
New York, NY |
May 15, 2025 Q1 2025 |
5,000,000
shares
|
$44.4 Million
0.61% of portfolio
|
Q1 2025
Reduced 21.88%
|
|
Nea Management Company, LLC
Timonium, MD |
May 14, 2025 Q1 2025 |
3,969,834
shares
|
$35.3 Million
3.03% of portfolio
|
Q1 2022
Added 29.32%
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
2,851,166
shares
|
$25.3 Million
0.0% of portfolio
|
Q1 2025
Reduced 2.29%
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
2,367,762
shares
|
$21 Million
0.0% of portfolio
|
Q1 2025
Added 43.93%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
1,971,806
shares
|
$17.5 Million
0.0% of portfolio
|
Q1 2025
Added 13.98%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
1,734,300
shares
|
$15.4 Million
0.0% of portfolio
|
Q1 2025
Reduced 1.71%
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
May 14, 2025 Q1 2025 |
1,640,432
shares
|
$14.6 Million
0.01% of portfolio
|
Q1 2025
Added 52.47%
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
1,631,482
shares
|
$14.5 Million
0.0% of portfolio
|
Q1 2025
Reduced 6.89%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,492,301
shares
|
$13.3 Million
0.0% of portfolio
|
Q4 2024
Added 10.19%
|
|
Nuveen, LLC
Charlotte, NC |
May 12, 2025 Q1 2025 |
1,245,549
shares
|
$11.1 Million
0.0% of portfolio
|
Q1 2025
New holding
|
|
Lazard Asset Management LLC
New York, NY |
May 15, 2025 Q1 2025 |
1,245,032
shares
|
$11.1 Million
0.02% of portfolio
|
Q1 2025
Added 108.76%
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
1,040,530
shares
|
$9.24 Million
2.74% of portfolio
|
Q3 2023
Added 81.43%
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
1,027,483
shares
|
$9.12 Million
0.0% of portfolio
|
Q1 2025
Reduced 2.55%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
938,600
shares
|
$8.33 Million
0.01% of portfolio
|
Q1 2025
Added 33.91%
|
|
Qube Research & Technologies LTD
London, X0 |
May 15, 2025 Q1 2025 |
856,148
shares
|
$7.6 Million
0.01% of portfolio
|
Q1 2025
Added 337.35%
|
|
Jupiter Asset Management LTD
|
May 09, 2025 Q1 2025 |
752,769
shares
|
$6.68 Million
0.06% of portfolio
|
Q1 2025
New holding
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
May 12, 2025 Q1 2025 |
746,229
shares
|
$6.63 Million
0.03% of portfolio
|
Q1 2025
Added 34.1%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
701,502
shares
|
$6.23 Million
0.0% of portfolio
|
Q1 2025
Reduced 24.35%
|
|
Trexquant Investment LP
Stamford, CT |
May 14, 2025 Q1 2025 |
700,638
shares
|
$6.22 Million
0.07% of portfolio
|
Q1 2025
Added 58.51%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
521,416
shares
|
$4.63 Million
0.0% of portfolio
|
Q1 2025
Reduced 21.6%
|
|
Aqr Capital Management LLC
Greenwich, CT |
May 15, 2025 Q1 2025 |
503,543
shares
|
$4.47 Million
0.0% of portfolio
|
Q1 2025
Added 8.72%
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
500,416
shares
|
$4.44 Million
0.03% of portfolio
|
Q1 2025
Reduced 41.09%
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
397,171
shares
|
$3.53 Million
0.0% of portfolio
|
Q1 2025
Added 520.82%
|